A population analysis of nebulized (R)-albuterol in dogs using a novel mixed gut-lung absorption PK-PD model

Pharmaceutical Research

Volumn 17, Issue 10, 2000, Pages 1228-1235

  Auclair, B ^a   Wainer, I W ^a,b   Fried, K ^b   Koch, P ^c   Jerussi, T P ^c   Ducharme, M P ^a,d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b GEORGETOWN UNIVERSITY   (United States)

^c DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^d MDS Inc   (Canada)

Author keywords

(R) albuterol; Enantiomer; Nebulization; Pharmacodynamics; Population pharmacokinetic analysis

Indexed keywords

SALBUTAMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG TOLERANCE; FEMALE; HEART RATE; MALE; NEBULIZATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0033637272     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026466730347     Document Type: Article

References (34)

1. Albuterol: An adrenergic agent for use in the treatment of asthma. Pharmacology, pharmacokinetics and clinical use
2. Enantioselective disposition of salbutamol in man following oral and intravenous administration
3. Pharmacokinetics and pharmacodynamics of single oral doses of albuterol and its enantiomers in humans
4. Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells
5. Three-dimensional view of pharmacology
6. Nebulized salbutamol (albuterol): Systemic absorption could be important in achieving bronchodilatation
7. Determination of the enantiomers of albuterol in human and canine plasma by enantioselective high-performance liquid chromatography on a teicoplanin-based chiral stationary phase
8. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling
9. Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin
10. Alternative approaches to estimation of population pharmacokinetic parameters: Comparison with the nonlinear mixed-effect model
11. The fate of nebulized salbutamol (albuterol) administered by intermittent positive pressure respiration to asthmatic patients
12. The effect of different nebulizers with and without intermittent positive pressure breathing on the absorption and metabolism of salbutamol
13. Plasma levels and effects of salbutamol after inhaled or i.v. administration in stable asthma
14. 3H-terbutaline sulphate administered to man as an aerosol
15. The fate of inhaled terbutaline
16. Biphasic effect-time courses in man after formoterol inhalation: Eosinopenic and hypokaliemic effects and inhibition of allergic skin reactions
17. Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol enantiomers in asthmatic subjects
18. Deposition of pressurized aerosols in the human respiratory tract
19. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction
20. The clinical pharmacology of oral and inhaled salbutamol
21. Hepatic and extrahepatic metabolism of salbutamol in anesthetized rabbits
22. (-)-Salbutamol sulphation in the human liver and duodenal mucosa: Interindividual variability
23. Metabolic studies of salbutamol-3H: A new bronchodilator, in rat, rabbit, dog and man
24. Clinical pharmacokinetics of β-Agonists
25. Enantiomeric interaction in the sulfate conjugation of the β2-agonist drug albuterol by the human liver
26. Subsensitivity of beta-adrenoceptor responses in asthmatic patients taking regular low dose inhaled salbutamol
27. The effects of salbutamolon blood pressure and heart rate in large white and pietrain-cross breeds of pig
28. Tachyphylaxis to systemic but not airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics
29. Tolerance to the bronchoprotective effect of beta2-agonists: Comparison of the enantiomers of salbutamol with racemic salbutamol and placebo
30. Does tachyphylaxis occur to the non-pulmonary effects of salmeterol?
31. Comparison of tremor responses to orally administered albuterol and terbutaline